neostigmine has been researched along with Sleep Apnea, Central in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Sleep Apnea, Central: A condition associated with multiple episodes of sleep apnea which are distinguished from obstructive sleep apnea (SLEEP APNEA, OBSTRUCTIVE) by the complete cessation of efforts to breathe. This disorder is associated with dysfunction of central nervous system centers that regulate respiration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This indicates that the primary cause of central apnea is muscarinic receptor-mediated in response to acetylcholine excess." | 1.91 | The lesion site of organophosphorus-induced central apnea and the effects of antidotes. ( Narimatsu, E; Nomura, K; Oke, Y; Oku, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nomura, K | 1 |
| Narimatsu, E | 1 |
| Oke, Y | 1 |
| Oku, Y | 1 |
1 other study available for neostigmine and Sleep Apnea, Central
| Article | Year |
|---|---|
The lesion site of organophosphorus-induced central apnea and the effects of antidotes.
Topics: Animals; Antidotes; Atropine; Neostigmine; Paraoxon; Pralidoxime Compounds; Pyridines; Rats; Rats, S | 2023 |